Impact on body composition and Sugar metabolism and Lipid metabolism by Diet therapy of BCAA or EPA added diet to patients with obesity type 2 diabetes

Impact on body composition and Sugar metabolism and Lipid metabolism by Diet therapy of BCAA or EPA added diet to patients with obesity type 2 diabetes - Impact on body composition and Sugar metabolism and Lipid metabolism by Diet therapy to patients with obesity type 2 diabetes

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000023441

Enrollment

Registered

2016-08-08

Start date

2016-08-05

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

obesity type 2 diabetes

Interventions

Intake of BCAA,EPA,DHA food intake over a period of 90 days Intake of BCAA,placebo food intake over a period of 90 days Intake of EPA,DHA food intake over a period of 90 days Intake of placebo food in

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patient BMI22kg /m2 or more of obese type 2 diabetes

Exclusion criteria

Exclusion criteria: 1.expectant and nursing mothers 2.ckd classification 3 period or more 3.cirrhosis of the liver 4.chronic pancreatitis (decompensated stage) 5.gastrointestinal disorders 6.there is a history of severe hypoglycemia 7.some of the heart pacemaker implantation 8.some of the contracture 9.if there is a taking of sglt2 inhibitors as drug therapy

Design outcomes

Primary

Measure	Time frame
the amount of change in the skeletal muscle by dietary intake BCAA,EPA,BCAA load diet before and after 90 days	—

Countries

Japan

Contacts

Public Contactrie sekine

The University of Tokyo Hospital Department of Clinical Nutrition Therapy

kine-tky@umin.ac.jp03-5800-9447

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026